Loading...

SciClone Pharmaceuticals, Inc.

SCLNNASDAQ
$11.15
$0.00(0.00%)

SciClone Pharmaceuticals, Inc. (SCLN) Company Profile & Overview

Explore SciClone Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

SciClone Pharmaceuticals, Inc. (SCLN) Company Profile & Overview

SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.

Company Facts

IPO DateMar 17, 1992

Frequently Asked Questions

;